Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04165850
Recruitment Status : Recruiting
First Posted : November 18, 2019
Last Update Posted : November 26, 2019
Sponsor:
Information provided by (Responsible Party):
NeuroSense Therapeutics Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : May 2021